Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIT (UNAUDITED)

v3.23.1
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIT (UNAUDITED) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2021 $ 355,301 $ 118,065,699 $ (122,594,000) $ (4,173,000)
Balance at beginning, shares at Dec. 31, 2021 355,300,222      
Common stock issued on conversion of notes payable $ 367 5,633 6,000
Common stock issued on conversion of notes payable, shares 366,666      
Common stock issued on exercise of warrants $ 825 24,175 25,000
Common stock issued on exercise of warrants, shares 825,000      
Fair value of warrants issued as compensation 24,000 24,000
Net loss (301,000) (301,000)
Ending balance, value at Mar. 31, 2022 $ 356,493 118,119,507 (122,895,000) (4,419,000)
Balance at ending, shares at Mar. 31, 2022 356,491,888      
Beginning balance, value at Dec. 31, 2022 $ 376,075 119,075,925 (124,142,000) (4,690,000)
Balance at beginning, shares at Dec. 31, 2022 376,074,096      
Common stock issued on conversion of notes payable $ 7,480 136,520 144,000
Common stock issued on conversion of notes payable, shares 7,480,000      
Warrants issued with convertible notes 47,000 47,000
Common stock issued on exercise of warrants $ 983 38,017 39,000
Common stock issued on exercise of warrants, shares 983,330      
Fair value of warrants issued as compensation 9,000 9,000
Net loss (334,000) (334,000)
Ending balance, value at Mar. 31, 2023 $ 384,538 $ 119,306,462 $ (124,476,000) $ (4,785,000)
Balance at ending, shares at Mar. 31, 2023 384,537,426